S
Sutro Biopharma D
D
STRO
1.77000
USD
-0.06
(-3.28%)
مغلق
حجم التداول
23,958
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
145,951,943
المقالات
العنوان: Sutro Biopharma
القطاع: Healthcare
الصناعة: Biotechnology
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancerand autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.